Intrinsic Value of S&P & Nasdaq Contact Us

Ensysce Biosciences, Inc. ENSC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
51/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ENSC

Ensysce Biosciences, Inc. (ENSC) has a market capitalization of $4.82M and trades at $0.52. The 52-week range is 0.314-4.85.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-3.98.

The stock has a beta of 1.16, operates in the Healthcare sector.

Trading Data
Current Price$0.52
52-Week Range0.314-4.85
Volume201.45K
Avg Volume (30D)6.24M
Market Cap$4.82M
Beta (1Y)1.16
Company
IPO Date2018-03-14
Employees7
CEOD. Lynn Kirkpatrick
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS2936025046
CUSIP293602108
Income (Latest Year)
EBITDA$-10.15M
Operating Income$-10.24T
Net Income$-10.18T
EPS$-3.98
EPS Diluted$-397,896.00
Shares Outstanding$2.56M
Balance Sheet (Latest Year)
Total Assets$7.45T
Current Assets$7.24T
Cash & ST Investments$4.31T
Total Liabilities$4.57T
Total Debt$306.71B
Net Debt$-4T
Total Equity$2.88T
Debt / Equity0.11
Valuation Ratios
P/E Ratio-0.1
P/B Ratio0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message